Telemus Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-993
Closed -$457K 328
2023
Q1
$457K Sell
993
-16
-2% -$7.61K 0.04% 227
2022
Q4
$480K Buy
1,009
+101
+11% +$51.3K 0.04% 228
2022
Q3
$412K Sell
908
-206
-18% -$98.6K 0.04% 220
2022
Q2
$538K Sell
1,114
-345
-24% -$171K 0.05% 232
2022
Q1
$717K Sell
1,459
-8
-0.5% -$3.66K 0.06% 201
2021
Q4
$680K Buy
1,467
+25
+2% +$10.5K 0.06% 215
2021
Q3
$538K Hold
1,442
0.05% 229
2021
Q2
$551K Buy
1,442
+20
+1% +$7.64K 0.04% 233
2021
Q1
$505K Sell
1,422
-75
-5% -$24.1K 0.03% 270
2020
Q4
$481K Hold
1,497
0.04% 261
2020
Q3
$444K Buy
1,497
+35
+2% +$9.42K 0.03% 325
2020
Q2
$373K Hold
1,462
0.03% 310
2020
Q1
$430K Sell
1,462
-178
-11% -$48.5K 0.04% 268
2019
Q4
$495K Sell
1,640
-200
-11% -$55K 0.04% 249
2019
Q3
$442K Sell
1,840
-23
-1% -$6.3K 0.04% 259
2019
Q2
$528K Sell
1,863
-300
-14% -$81.9K 0.05% 231
2019
Q1
$621K Sell
2,163
-2,455
-53% -$710K 0.05% 247
2018
Q4
$1.21M Sell
4,618
-101
-2% -$27.8K 0.1% 153
2018
Q3
$1.29M Sell
4,719
-3,260
-41% -$846K 0.1% 160
2018
Q2
$1.9M Buy
7,979
+735
+10% +$170K 0.15% 126
2018
Q1
$1.59M Sell
7,244
-87
-1% -$20.4K 0.13% 144
2017
Q4
$1.65M Buy
7,331
+644
+10% +$137K 0.13% 137
2017
Q3
$1.27M Sell
6,687
-2,742
-29% -$522K 0.14% 111
2017
Q2
$1.77M Buy
9,429
+397
+4% +$71.3K 0.18% 97
2017
Q1
$1.49M Buy
9,032
+3,037
+51% +$483K 0.16% 107
2016
Q4
$862K Sell
5,995
-433
-7% -$58K 0.12% 136
2016
Q3
$805K Buy
6,428
+1,880
+41% +$243K 0.09% 165
2016
Q2
$597K Buy
4,548
+2,200
+94% +$301K 0.07% 189
2016
Q1
$326K Buy
+2,348
New +$314K 0.05% 243

Other funds holding ELV